Study name | Identifiera | Purpose | Biomarker(s) |
---|---|---|---|
Detection and diagnosis of NSCLC | |||
 Prospective blinded evaluation of salivary transcriptome biomarkers for NSCLC detection | NCT02294578 | Evaluate sensitivity and specificity of biomarkers (mRNA) from saliva of patients with lung lesions prior to cancer diagnosis | BRAF, CCNI, EGFR, FGF19, FRS2, GREB1, and LZTS1 |
 Molecular Diagnosis on circulating tumor DNA of NSCLC (ANTiCIPe) | NCT02169349 | Develop an assay to detect DNA mutation in circulating tumor DNA (from plasma) for diagnosis, treatment, and monitoring cancer progression of NSCLC (stage IIIb and IV) | N/S |